Levetiracetam modulates brain metabolic networks and transcriptomic signatures in the 5XFAD mouse model of Alzheimer's disease.

Front Neurosci · 2023 · PMC10847229 · PMID 38328556

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

trending toward significancep = 0.057so close (0.05 < p ≤ 0.1)

Males treated chronically with a low dose (10 mg/kg) of LEV yielded a more normally distributed set of edgewise covariance trending toward significance compared to the vehicle (saline) treatment group of the same sex (KS = 0.01, p = 0.057).

also in 100 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.